FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1487808142> ?p ?o ?g. }

• W1487808142 endingPage "707" @default.
• W1487808142 startingPage "699" @default.
• W1487808142 abstract "Object Cyclosporine neuroprotection has been reported in brain injury models but safety and dosing guidelines have not been determined in humans with severe traumatic brain injury (TBI). The purpose of this investigation was to establish the safety of cyclosporine using 4 clinically relevant dosing schemes. Methods The authors performed a prospective, blinded, placebo-controlled, randomized, dose-escalation trial of cyclosporine administration initiated within 8 hours of TBI (Glasgow Coma Scale score range 4–8; motor score range 2–5). Four dosing cohorts (8 patients treated with cyclosporine and 2 receiving placebo treatment per cohort) received cyclosporine (1.25–5 mg/kg/day) or placebo in 2 divided doses (Cohorts I–III) or continuous infusion (Cohort IV) over 72 hours. Adverse events and outcome were monitored for 6 months. Results Forty patients were enrolled over 3 years (cyclosporine cohorts, 24 male and 8 female patients; placebo group, 8 male patients). Systemic trough concentrations were below 250 ng/ml during intermittent doses. Higher blood concentrations were observed in Cohorts III and IV. There was no significant difference in immunological effects, adverse events, infection, renal dysfunction, or seizures. Mortality rate was not affected by cyclosporine administration, independent of dose, compared with placebo (6 of 32 patients receiving cyclosporine and 2 of 8 receiving placebo died, p > 0.05). At 6 months, a dose-related improvement in favorable outcome was observed in cyclosporine-treated patients (p < 0.05). Conclusions In patients with acute TBI who received cyclosporine at doses up to 5 mg/kg/day, administered intravenously, with treatment initiated within 8 hours of injury, the rate of mortality or other adverse events was not significantly different from that of the placebo group." @default.
• W1487808142 created "2016-06-24" @default.
• W1487808142 creator A5026731244 @default.
• W1487808142 creator A5038574556 @default.
• W1487808142 creator A5074313960 @default.
• W1487808142 creator A5081688346 @default.
• W1487808142 creator A5087027179 @default.
• W1487808142 date "2008-10-01" @default.
• W1487808142 modified "2023-10-16" @default.
• W1487808142 title "Dosing and safety of cyclosporine in patients with severe brain injury" @default.
• W1487808142 cites W145468704 @default.
• W1487808142 cites W1494460016 @default.
• W1487808142 cites W1563833920 @default.
• W1487808142 cites W1575775219 @default.
• W1487808142 cites W1618670194 @default.
• W1487808142 cites W1752979806 @default.
• W1487808142 cites W1758018633 @default.
• W1487808142 cites W1948023428 @default.
• W1487808142 cites W1965074869 @default.
• W1487808142 cites W1984925481 @default.
• W1487808142 cites W1986222379 @default.
• W1487808142 cites W1989639507 @default.
• W1487808142 cites W1992890638 @default.
• W1487808142 cites W1994455025 @default.
• W1487808142 cites W1998919607 @default.
• W1487808142 cites W2000057840 @default.
• W1487808142 cites W2000620316 @default.
• W1487808142 cites W2004496970 @default.
• W1487808142 cites W2004667116 @default.
• W1487808142 cites W2007005170 @default.
• W1487808142 cites W2008225353 @default.
• W1487808142 cites W2009105636 @default.
• W1487808142 cites W2016205446 @default.
• W1487808142 cites W2021439672 @default.
• W1487808142 cites W2022248426 @default.
• W1487808142 cites W2026298348 @default.
• W1487808142 cites W2026747237 @default.
• W1487808142 cites W2027865643 @default.
• W1487808142 cites W2029508003 @default.
• W1487808142 cites W2033624750 @default.
• W1487808142 cites W2038504360 @default.
• W1487808142 cites W2043435036 @default.
• W1487808142 cites W2045663952 @default.
• W1487808142 cites W2048091182 @default.
• W1487808142 cites W2049481822 @default.
• W1487808142 cites W2049483605 @default.
• W1487808142 cites W2052647454 @default.
• W1487808142 cites W2058721062 @default.
• W1487808142 cites W2062007753 @default.
• W1487808142 cites W2062754118 @default.
• W1487808142 cites W2065730275 @default.
• W1487808142 cites W2067487401 @default.
• W1487808142 cites W2068718608 @default.
• W1487808142 cites W2077518243 @default.
• W1487808142 cites W2079730704 @default.
• W1487808142 cites W2084066290 @default.
• W1487808142 cites W2085935734 @default.
• W1487808142 cites W2088877150 @default.
• W1487808142 cites W2091021351 @default.
• W1487808142 cites W209381521 @default.
• W1487808142 cites W2096869950 @default.
• W1487808142 cites W2101577668 @default.
• W1487808142 cites W2117779132 @default.
• W1487808142 cites W2130446116 @default.
• W1487808142 cites W2145126747 @default.
• W1487808142 cites W2149707501 @default.
• W1487808142 cites W2150348931 @default.
• W1487808142 cites W2161205313 @default.
• W1487808142 cites W2162888309 @default.
• W1487808142 cites W2170602294 @default.
• W1487808142 cites W225299234 @default.
• W1487808142 cites W2398393335 @default.
• W1487808142 cites W2414594846 @default.
• W1487808142 cites W4006971 @default.
• W1487808142 cites W976170812 @default.
• W1487808142 doi "https://doi.org/10.3171/jns/2008/109/10/0699" @default.
• W1487808142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2770729" @default.
• W1487808142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18826358" @default.
• W1487808142 hasPublicationYear "2008" @default.
• W1487808142 type Work @default.
• W1487808142 sameAs 1487808142 @default.
• W1487808142 citedByCount "97" @default.
• W1487808142 countsByYear W14878081422012 @default.
• W1487808142 countsByYear W14878081422013 @default.
• W1487808142 countsByYear W14878081422014 @default.
• W1487808142 countsByYear W14878081422015 @default.
• W1487808142 countsByYear W14878081422016 @default.
• W1487808142 countsByYear W14878081422017 @default.
• W1487808142 countsByYear W14878081422018 @default.
• W1487808142 countsByYear W14878081422019 @default.
• W1487808142 countsByYear W14878081422020 @default.
• W1487808142 countsByYear W14878081422021 @default.
• W1487808142 countsByYear W14878081422022 @default.
• W1487808142 countsByYear W14878081422023 @default.
• W1487808142 crossrefType "journal-article" @default.
• W1487808142 hasAuthorship W1487808142A5026731244 @default.
• W1487808142 hasAuthorship W1487808142A5038574556 @default.
• W1487808142 hasAuthorship W1487808142A5074313960 @default.

• next